Genesis IBRC

{
  "main_header": {
    "sid": 187665,
    "name": "Genesis IBRC",
    "stock_name": "Genesis IBRC",
    "full_name": "Genesis IBRC India Ltd",
    "name_url": "stocks-analysis/genesis-ibrc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "72.94",
    "chg": -3.83,
    "chgp": "-4.99%",
    "dir": -1,
    "prev_price": "76.77",
    "mcapval": "95.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 514336,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 40,
    "indexname": "",
    "isin": "INE194N01016",
    "curr_date": "Feb 11",
    "curr_time": "",
    "bse_nse_vol": "351 ",
    "exc_status": "Active",
    "traded_date": "Feb 11, 2026",
    "traded_date_str": "2026 02 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/genesis-ibrc-187665-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Genesis IBRC India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-is-rated-sell-3827199",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GenesisIBRCIndi_mojoScore_3827199.png",
        "date": "2026-02-08 10:10:29",
        "description": "Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 08 February 2026, providing investors with the latest comprehensive analysis."
      },
      {
        "title": "Genesis IBRC India Ltd Upgraded to Sell by MarketsMOJO Amid Flat Financials and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-upgraded-to-sell-by-marketsmojo-amid-flat-financials-and-valuation-concerns-3806769",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GenesisIBRCIndi_mojoScore_3806769.png",
        "date": "2026-01-28 08:05:02",
        "description": "Genesis IBRC India Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 27 Jan 2026, reflecting a nuanced shift in its financial and market outlook. Despite persistent challenges in profitability and valuation, certain technical and financial trend parameters have shown stabilisation, prompting a reassessment of the company’s investment appeal within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Genesis IBRC India Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-concerns-3797655",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GenesisIBRCIndi_mojoScore_3797655.png",
        "date": "2026-01-21 08:02:31",
        "description": "Genesis IBRC India Ltd has been downgraded from a Sell to a Strong Sell rating as of 20 Jan 2026, reflecting deteriorating technical indicators and valuation concerns despite its impressive long-term returns. The downgrade follows a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals, signalling caution for investors amid flat recent financial performance and mixed market signals."
      },
      {
        "title": "Genesis IBRC India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-is-rated-sell-3783203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GenesisIBRCIndi_mojoScore_3783203.png",
        "date": "2026-01-06 10:10:10",
        "description": "Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Genesis IBRC India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-india-ltd-is-rated-sell-3769916",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GenesisIBRCIndi_mojoScore_3769916.png",
        "date": "2025-12-25 15:12:04",
        "description": "Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date perspective on the company's performance and outlook."
      },
      {
        "title": "Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genesis-ibrc-india-faces-severe-selling-pressure-hits-lower-circuit-amid-prolonged-downtrend-3748081",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GenesisIBRCIndi_only_sellers_3748081.png",
        "date": "2025-12-05 09:40:12",
        "description": "Genesis IBRC India Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 5.0% today and exhibiting a persistent downward trend over the past 18 trading sessions. The absence of buyers and the presence of only sell orders have intensified concerns about distress selling within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Genesis IBRC Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-upgraded-to-sell-rating-by-marketsmojo-amid-mixed-fundamentals-3746535",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GenesisIBRC_mojoScore_3746535.png",
        "date": "2025-12-04 11:08:06",
        "description": "Genesis IBRC, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation metrics, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of volatile stock returns and a complex fundamental profile."
      },
      {
        "title": "Genesis IBRC India Faces Intense Selling Pressure Amid Lower Circuit Lockdown",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genesis-ibrc-india-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3745828",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GenesisIBRCIndi_only_sellers_3745828.png",
        "date": "2025-12-04 09:35:10",
        "description": "Genesis IBRC India Ltd has encountered severe selling pressure on 4 Dec 2025, with the stock hitting the lower circuit and registering exclusively sell orders. This distress selling signals a critical phase for the pharmaceutical and biotechnology company as it experiences consecutive losses and a sharp decline in market sentiment."
      },
      {
        "title": "Genesis IBRC India Faces Intense Selling Pressure Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genesis-ibrc-india-faces-intense-selling-pressure-amid-prolonged-downtrend-3743298",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GenesisIBRCIndi_only_sellers_3743298.png",
        "date": "2025-12-03 09:40:10",
        "description": "Genesis IBRC India Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.97% today and exhibiting a persistent downtrend over the past sixteen trading sessions. The absence of buyers and continuous sell orders have resulted in a distressing market scenario for this Pharmaceuticals & Biotechnology company."
      }
    ],
    "total": 176,
    "sid": "187665",
    "stock_news_url": "https://www.marketsmojo.com/news/genesis-ibrc-india-187665"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Feb-2026",
      "details": "Newspaper publications for sending out postal ballot notice to shareholders.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "02-Feb-2026",
      "details": "Notice of Postal Ballot for Genesis IBRC India Limited.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 28-01-2026",
      "datetime": "28-Jan-2026",
      "details": "The Board of Directors of Genesis IBRC India Limited (Company) in their meeting held today i.e. Wednesday January 28 2026 have inter alia considered recommended and approved the matters as specified in the outcome of board meeting.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Genesis IBRC India Ltd is Rated Sell

2026-02-08 10:10:29

Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 08 February 2026, providing investors with the latest comprehensive analysis.

Read full news article

Genesis IBRC India Ltd Upgraded to Sell by MarketsMOJO Amid Flat Financials and Valuation Concerns

2026-01-28 08:05:02

Genesis IBRC India Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 27 Jan 2026, reflecting a nuanced shift in its financial and market outlook. Despite persistent challenges in profitability and valuation, certain technical and financial trend parameters have shown stabilisation, prompting a reassessment of the company’s investment appeal within the Pharmaceuticals & Biotechnology sector.

Read full news article

Genesis IBRC India Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns

2026-01-21 08:02:31

Genesis IBRC India Ltd has been downgraded from a Sell to a Strong Sell rating as of 20 Jan 2026, reflecting deteriorating technical indicators and valuation concerns despite its impressive long-term returns. The downgrade follows a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals, signalling caution for investors amid flat recent financial performance and mixed market signals.

Read full news article

Genesis IBRC India Ltd is Rated Sell

2026-01-06 10:10:10

Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Genesis IBRC India Ltd is Rated Sell

2025-12-25 15:12:04

Genesis IBRC India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date perspective on the company's performance and outlook.

Read full news article

Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-05 09:40:12

Genesis IBRC India Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 5.0% today and exhibiting a persistent downward trend over the past 18 trading sessions. The absence of buyers and the presence of only sell orders have intensified concerns about distress selling within the Pharmaceuticals & Biotechnology sector.

Read full news article

Genesis IBRC Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-04 11:08:06

Genesis IBRC, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation metrics, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of volatile stock returns and a complex fundamental profile.

Read full news article

Genesis IBRC India Faces Intense Selling Pressure Amid Lower Circuit Lockdown

2025-12-04 09:35:10

Genesis IBRC India Ltd has encountered severe selling pressure on 4 Dec 2025, with the stock hitting the lower circuit and registering exclusively sell orders. This distress selling signals a critical phase for the pharmaceutical and biotechnology company as it experiences consecutive losses and a sharp decline in market sentiment.

Read full news article

Genesis IBRC India Faces Intense Selling Pressure Amid Prolonged Downtrend

2025-12-03 09:40:10

Genesis IBRC India Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.97% today and exhibiting a persistent downtrend over the past sixteen trading sessions. The absence of buyers and continuous sell orders have resulted in a distressing market scenario for this Pharmaceuticals & Biotechnology company.

Read full news article

View All News